Matinas biopharma announces positive in vivo efficacy results of oral lnc docetaxel formulation in a melanoma model

Study results show reduction in tumor size comparable to iv docetaxel and no systemic toxicity study results show reduction in tumor size comparable to iv docetaxel and no systemic toxicity
MTNB Ratings Summary
MTNB Quant Ranking